Focused Alpha’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Focused Alpha's NVS Position: Q3 2026 in Review
Focused Alpha increased its Novartis (NVS) stake by 4.9% in Q3 2026, buying an estimated $10.9K and bringing the position to 1,556 shares worth $222K. The position accounts for 0.06% of the portfolio, ranked #241.
Focused Alpha first reported a position in NVS in Q2 2026 and has held it in 2 quarters since. The position peaked at $233K in Q2 2026. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Focused Alpha held 1,556 shares of Novartis worth $222K as of Q3 2026.
- Focused Alpha bought 72 Novartis shares in Q3 2026, an estimated $10.9K.
- Novartis made up 0.06% of Focused Alpha's portfolio in Q3 2026, its #241 holding.
- Focused Alpha first reported a position in Novartis in Q2 2026 and has held it in 2 quarters since.
- Focused Alpha's Novartis position peaked at $233K in Q2 2026.
- 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Focused Alpha's 13F filing for Q3 2026, filed 20 Oct 2026.